Sunwin International Neutraceuticals to Aggressively Pursue Opportunities in Europe After the European Commission's Recent Regulatory Approval of Stevia

QUFU, China, Nov. 15, 2011 /PRNewswire/ -- Sunwin International Neutraceuticals, Inc. (OTC.BB: SUWN), one of the top global providers of high quality Stevia extracts including Rebaudioside A 98, announced today that management intends to aggressively pursue opportunities in Europe after the European Commission's ("EC's")recent approval of Stevia for use in the food and beverage industry. In May of 2011 Sunwin announced a collaboration with two major companies in the flavouring and sweetener industry, ...continued SUWN  shares Services shandong

URL: http://www.investorpoint.com/news/OTCBULLB/46139401/